However, most studies focused on the expression of NRP1 in the tumor cells themselves [12,13], where it is differentially expressed in the various molecular subgroups associated with poor prognosis, as it is involved in promoting metastasis, angiogenesis, and overall tumor progression. The gene discussed is NRP1; the disease is neoplasm.